SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 0.00 |
| Enterprise Value ($M) | 271.32 |
| Book Value ($M) | 38.45 |
| Book Value / Share | 0.34 |
| Price / Book | 0.00 |
| NCAV ($M) | -161.75 |
| NCAV / Share | -1.43 |
| Price / NCAV | 0.00 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.14 |
| Return on Assets (ROA) | 0.12 |
| Return on Equity (ROE) | 10.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.99 |
| Current Ratio | 1.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 298.35 |
| Assets | 498.55 |
| Liabilities | 460.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Hoche Partners Pharma Holding S.A. | 14.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 476 | 686 | 69.39 | |
| 465 | 103 | 451.46 | |
| 20 | 10 | 200.00 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OCUL – Ocular Therapeutix, Inc. | OMER – Omeros Corporation |
| PAHC – Phibro Animal Health Corporation | PTGX – Protagonist Therapeutics, Inc. |
| PWUP – PowerUp Acquisition Corp. |
Financial data and stock pages provided by
Fintel.io